Demant A/S: Demant to resume share buy-backs
Company announcement no 2023-14 21 November 2023
Demant to resume share buy-backs
It has previously been announced that the Group may resume its share buy-backs in 2023. In line with this, Demant announces today that it has decided to resume its share buy-backs following material deleveraging during 2023 thanks to strong cash flow generation throughout the year. Also, the level of acquisitions has been lower than originally planned, as some acquisitions are now expected to close in 2024.
There are no changes to the Group’s outlook for 2023, and the gearing multiple (NIBD/EBITDA) at the end of 2023 is still expected to be within the medium- to long-term target of 2.0-2.5.
|
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 |
Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communication |
Contacts
Henrik Axel Lynge Buchter
External Communication Manager
Corporate Communication & Sustainability
Tel:
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom